These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 17878399)

  • 21. Adenosine Selectively Depletes Alloreactive T Cells to Prevent GVHD While Conserving Immunity to Viruses and Leukemia.
    Whitehill GD; Amarnath S; Muranski P; Keyvanfar K; Battiwalla M; Barrett AJ; Chinnassamy D
    Mol Ther; 2016 Sep; 24(9):1655-64. PubMed ID: 27401140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alloreactive and leukemia-reactive T cells are preferentially derived from naive precursors in healthy donors: implications for immunotherapy with memory T cells.
    Distler E; Bloetz A; Albrecht J; Asdufan S; Hohberger A; Frey M; Schnürer E; Thomas S; Theobald M; Hartwig UF; Herr W
    Haematologica; 2011 Jul; 96(7):1024-32. PubMed ID: 21486863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of alloantigen-specific anergy in human peripheral blood mononuclear cells by alloantigen stimulation with co-stimulatory signal blockade.
    Davies JK; Barbon CM; Voskertchian AR; Nadler LM; Guinan EC
    J Vis Exp; 2011 Mar; (49):. PubMed ID: 21445041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of graft-versus-host disease while preserving graft-versus-leukemia effect after selective depletion of host-reactive T cells by photodynamic cell purging process.
    Chen BJ; Cui X; Liu C; Chao NJ
    Blood; 2002 May; 99(9):3083-8. PubMed ID: 11964269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of one-HLA-haplotype-matched and HLA-mismatched blood transfusions on recipient T lymphocyte allorepertoires.
    Young NT; Roelen DL; Iggo N; Gray DW; Roake JA; Graham V; Wood KJ; Dallman MJ; Welsh KI; Morris PJ
    Transplantation; 1997 Apr; 63(8):1160-5. PubMed ID: 9133479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HSCT recipients have specific tolerance to MSC but not to the MSC donor.
    Sundin M; Barrett AJ; Ringdén O; Uzunel M; Lönnies H; Dackland AL; Christensson B; Blanc KL
    J Immunother; 2009 Sep; 32(7):755-64. PubMed ID: 19561533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specific depletion of alloreactive T cells in HLA-identical siblings: a method for separating graft-versus-host and graft-versus-leukaemia reactions.
    Mavroudis DA; Dermime S; Molldrem J; Jiang YZ; Raptis A; van Rhee F; Hensel N; Fellowes V; Eliopoulos G; Barrett AJ
    Br J Haematol; 1998 Jun; 101(3):565-70. PubMed ID: 9633903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Depletion of Alloreactive T-Cells by Anti-CD137-Saporin Immunotoxin.
    Lee SC; Seo KW; Kim HJ; Kang SW; Choi HJ; Kim A; Kwon BS; Cho HR; Kwon B
    Cell Transplant; 2015; 24(6):1167-81. PubMed ID: 24594433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative analysis of dendritic cells and anti-CD3/CD28 expanded regulatory T cells for application in transplantation.
    Zeng M; Guinet E; Nouri-Shirazi M
    Transpl Immunol; 2009 Dec; 22(1-2):82-92. PubMed ID: 19635560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
    Russell CA
    Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective depletion of alloreactive donor lymphocytes: a novel method to reduce the severity of graft-versus-host disease in older patients undergoing matched sibling donor stem cell transplantation.
    Solomon SR; Mielke S; Savani BN; Montero A; Wisch L; Childs R; Hensel N; Schindler J; Ghetie V; Leitman SF; Mai T; Carter CS; Kurlander R; Read EJ; Vitetta ES; Barrett AJ
    Blood; 2005 Aug; 106(3):1123-9. PubMed ID: 15817673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting T Cell Bioenergetics by Modulating P-Glycoprotein Selectively Depletes Alloreactive T Cells To Prevent Graft-versus-Host Disease.
    McIver ZA; Grayson JM; Coe BN; Hill JE; Schamerhorn GA; Ohulchanskyy TY; Linder MK; Davies KS; Weiner RS; Detty MR
    J Immunol; 2016 Sep; 197(5):1631-41. PubMed ID: 27456485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [T-cell-depleted HLA non-identical bone marrow transplantation in the child: prevention of graft-versus-host reaction by administration of donor T lymphocytes alloreactive against the recipient].
    Cavazzana-Calvo M; André-Schmutz I; Hacein-Bey S; Schindler J; Vitetta H; Dupuis S; Quartier P; Chedeville G; Vilmer E; Casanova JL; Buffet R; Caillat-Zucman S; Radford I; Le Deist F; Fischer A
    J Soc Biol; 2001; 195(1):65-8. PubMed ID: 11530503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Large-scale generation of human allodepleted anti-3rd party lymphocytes.
    De Ioanni M; Di Ianni M; Bonifacio E; Moretti L; Cecchini D; Bazzucchi F; Terenzi A; Aloisi T; Falzetti F; Aversa F; Reisner Y; Martelli MF; Tabilio A
    Blood Cells Mol Dis; 2008; 40(1):106-12. PubMed ID: 17931916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Poor immune reconstitution after four or five major HLA antigens mismatched T cell-depleted allogeneic and autologous stem cell transplantation.
    Mattsson J; Uzunel M; Remberger M; Tammik L; Omazic B; Levitsky V; Zou JZ; Hentschke P; Ringdén O
    Clin Exp Immunol; 2001 Jan; 123(1):162-9. PubMed ID: 11168014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Depletion of alloreactive T cells via CD69: implications on antiviral, antileukemic and immunoregulatory T lymphocytes.
    Hartwig UF; Nonn M; Khan S; Meyer RG; Huber C; Herr W
    Bone Marrow Transplant; 2006 Feb; 37(3):297-305. PubMed ID: 16327814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alloanergization Method for Inducing Allospecific Hyporesponsiveness in PBMC Exposed to Allostimulation In Vitro in the Context of Costimulatory Molecule Blockade.
    Barbon CM; Janec KJ; Kelner RH; Norton JE; Guinan EC
    Methods Mol Biol; 2019; 1899():103-118. PubMed ID: 30649768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alloreactive T cell clonotype recruitment in a mixed lymphocyte reaction: implications for graft engineering.
    Scheinberg P; Price DA; Ambrozak DR; Barrett AJ; Douek DC
    Exp Hematol; 2006 Jun; 34(6):788-95. PubMed ID: 16728284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of an anti-CD25 immunotoxin, Ontak and anti-CD25 microbeads for their ability to deplete alloreactive T cells in vitro.
    Vaclavkova P; Cao Y; Wu LK; Michalek J; Vitetta ES
    Bone Marrow Transplant; 2006 Mar; 37(6):559-67. PubMed ID: 16444279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation.
    Keever-Taylor CA; Passweg J; Kawanishi Y; Casper J; Flomenberg N; Baxter-Lowe LA
    Bone Marrow Transplant; 1997 May; 19(10):1001-9. PubMed ID: 9169644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.